Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Sanjie Formula (JPSJF) is a Traditional Chinese Medicine (TCM) herbal decoction primarily utilized as an adjuvant therapy for gastrointestinal malignancies, including gastric and colorectal cancers. The formula is designed based on the TCM principles of strengthening the spleen (Jianpi) to bolster the body's 'Zheng Qi' (vital energy) and resolving hard masses or nodules (Sanjie) to counteract tumor progression. Mechanistically, JPSJF has been shown to inhibit tumor cell proliferation, migration, and invasion by modulating various signaling pathways, such as the PI3K/Akt and Wnt/β-catenin pathways. It is also reported to regulate the tumor microenvironment, enhance immune function by balancing T-lymphocyte subsets, and reduce the systemic toxicity and side effects associated with conventional chemotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Sanjie Formula.